Skip to content

Clinical trials

Epistaxis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epistaxis Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20112
20121
20131
20142
20152
20161
20171
20193
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated2
Withdrawn2
Active, not recruiting2
Recruiting1
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cure HHT2
Alnylam Pharmaceuticals1
Columbia University1
Emory University1
HemCon Medical Technologies, Inc1
James Gossage1
Lisa Shnayder1
Mayo Clinic1
Mercy Health Ohio1
Nemours Children's Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epistaxis21
Telangiectasia, Hereditary Hemorrhagic12
Anemia2
Arteriovenous Malformations2
Vascular Malformations2
Gastrointestinal Hemorrhage1
Intracranial Arteriovenous Malformations1
Nasal Obstruction1
Rhinitis, Vasomotor1
Telangiectasis1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.